Jul 20, 2025 5:46 PM
BACK TO TOP
KSE100
138,597.36
-68.13
(-0.05%)
ALLSHR
85,286.15
-413.35
(-0.48%)
KSE30
42,340.80
-12.33
(-0.03%)
KMI30
193,554.51
-1627.52
(-0.83%)
BKTI
38,197.96
-225.01
(-0.59%)
OGTI
27,457.34
-260.91
(-0.94%)
KMIALLSHR
55,946.05
-443.10
(-0.79%)
PSXDIV20
55,760.33
-209.88
(-0.37%)
UPP9
47,268.35
469.47
(1.00%)
NITPGI
35,545.66
266.58
(0.76%)
NBPPGI
37,714.71
98.21
(0.26%)
MZNPI
23,277.82
-175.61
(-0.75%)
JSMFI
34,987.69
-704.13
(-1.97%)
ACI
20,427.56
-284.15
(-1.37%)
JSGBKTI
45,742.04
-277.15
(-0.60%)
MII30
17,829.25
-140.58
(-0.78%)
HBLTTI
16,995.15
17-07-2025
6.31
(0.04%)
KSE100PR
44,761.45
-97.72
(-0.22%)
BF Biosciences Limited
PHARMACEUTICALS
Rs.162.88
-0.76
(-0.46%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, Jul 18, 2025 4:48 PM
REG
FUT
ODL
Open
165.00
High
165.00
Low
162.40
Volume
153,973
CIRCUIT BREAKER
147.28 — 180.00
DAY RANGE
162.40 — 165.00
52-WEEK RANGE
74.55 — 253.97
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
163.64
VAR
17.50
HAIRCUT
22.50
P/E Ratio (TTM) **
N/A
1-Year Change *
-0.46%
YTD Change *
-30.65%

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

BF Biosciences Limited ("BFBL", "Company", or the "Issuer") was incorporated as an unlisted public limited company under the Companies Ordinance, 1984 (now Companies Act, 2017) in 2006, and operates within the pharmaceutical industry. BFBL is a 80%:20% joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina. The Company's core operations involve the import, manufacturing, marketing and distribution of pharmaceutical products.

KEY PEOPLE
Akhter Khalid WaheedCEO
Sebastian Martin FerrarassiChairperson
Abdur RehmanCompany Secretary
ADDRESS

197-A, The Mall, Rawalpindi, Pakistan

WEBSITE

www.bfbio.com

REGISTRAR

CDC Share Registrar Services Limited, CDC House, 99-B, Block-B, S.M.C.H.S, Main Shahrah Faisal, Karachi

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Equity Profile

Market Cap (000's)
14,387,733.44
Shares
88,333,334
Free Float
26,500,000
Free Float
30.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 30, 2025Transmission of Quarterly Report for the Period Ended 2025-03-31 View   PDF
Apr 29, 2025Financial Results for the Quarter Ended 2025-03-31 View   PDF
Apr 11, 2025Quarterly Progress Report for the Period Ended December 31, 2024 View   PDF
Feb 28, 2025Transmission of Quarterly Report for the Period Ended 31-12-2024 View   PDF
Feb 28, 2025Financial Results for the Quarter Ended 2024-12-31 View   PDF
Feb 28, 2025Financial Results for the Quarter Ended 2024-12-31
REVOKED
Oct 30, 2024Transmission of Quarterly Report for the Period Ended 2024-09-30 View   PDF
Oct 28, 2024Financial Results for the Quarter Ended 2024-09-30 View   PDF
Oct 25, 2024Transmission of Annual Report for the Year Ended 2024-06-30 View   PDF
DateTitleDocument
Jul 8, 2025Emergent Board Meeting Other Than Financial Results View   
Apr 21, 2025Board Meeting View   
Feb 20, 2025Board Meeting View   
Oct 28, 2024Certified true copy of the resolutions passed in the Annual General Meeting of the Company View   PDF
Oct 25, 2024Notice of Annual General Meeting View   PDF
Oct 23, 2024Board Meeting View   
DateTitleDocument
Apr 17, 2025Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jan 14, 2025Material Information View   PDF
Dec 24, 2024Clarification - Unusual Movement in Price of the Shares of the BF Biosciences Limited View   PDF
Nov 26, 2024Corporate Briefing Session - Presentation View   PDF
Nov 22, 2024Corporate Briefing Session View   PDF
Nov 14, 2024Material Informaiton View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
No Data Available
Q3 2025Q2 2025Q1 2025Q3 2024
Sales1,500,4691,327,2021,386,3722,915,514
Profit after Taxation124,52780,539115,273314,052
EPS1.591.091.824.96
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Payouts

Financial Reports